XML 18 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:      
Net loss $ (12,304) $ (1,479) $ (75,081)
Adjustments to reconcile net loss to net cash provided by operating activities:      
Depreciation and amortization 61,153 44,782 32,215
Provision for subscription cancellations and non-renewals, net of deferred allowance (196) 466 259
Amortization of deferred financing costs 245 211 373
Write-off of deferred financing costs 370   1,387
Stock-based compensation expense 19,729 26,160 147,904
Deferred income tax benefit (1,345) (3,116) (33,499)
Redemption of Converted SARs     (22,889)
Non-cash operating lease costs 3,357 3,825  
Other 4,052 510 107
Changes in operating assets and liabilities:      
Accounts receivable (25,665) 2,962 (6,762)
Prepaid expenses and other current assets (214) (5,192) (1,541)
Deferred commissions (2,908) (812) (547)
Accounts payable 1,369 3,847 (1,842)
Accrued expenses 15,064 3,210 4,568
Accrued and deferred compensation (12,005) (3,735) (632)
Deferred revenue 30,768 24,691 17,557
Operating lease liabilities (4,041) (4,697)  
Other (583) 336 (2,034)
Net cash provided by operating activities 76,846 91,969 59,543
Cash flows from investing activities:      
Acquisition of business, net of cash acquired (474) (251,412) (11,570)
Property and equipment additions (58,530) (33,386) (20,955)
Capitalized software additions (14,888) (11,660) (11,850)
Purchase of investment securities, available-for-sale (16,518)    
Proceeds from maturities of investment securities, available-for-sale 5,364    
Net cash used in investing activities (85,046) (296,458) (44,375)
Cash flows from financing activities:      
Net increase (decrease) in customer funds obligations (11,340) 14,226 1,681
Proceeds from line of credit     12,500
Principal payments on line of credit     (12,500)
Proceeds from term loan 50,000   175,000
Principal payments on long-term debt (938)   (226,251)
Payments for deferred financing costs (983)   (2,436)
Proceeds from issuance of shares in connection with Offering     423,024
Payments for Offering costs     (6,222)
Payments for taxes on exercised stock options     (14,813)
Proceeds from purchases of stock under ESPP 1,951 2,060 957
Payments for taxes related to net share settlement of stock-based awards (1,104) (12,758)  
Proceeds from exercise of stock options 1,821 1,859 8,808
Distributions to stockholders     (146,116)
Distributions under Tax Sharing Agreement (536) (2,700)  
Payments for purchase commitment liabilities (423) (10,822)  
Payments of finance lease liabilities (1,354) (964)  
Payments for deferred purchase commitments (20,000)    
Net cash provided by (used in) financing activities 17,094 (9,099) 213,632
Effect of exchange rate changes on cash, cash equivalents and restricted cash (352) (479) (22)
Net increase (decrease) in cash, cash equivalents and restricted cash 8,542 (214,067) 228,778
Cash, cash equivalents and restricted cash, beginning of period 98,206 312,273 83,495
Cash, cash equivalents and restricted cash, end of period $ 106,748 $ 98,206 $ 312,273